3rd Quarter - Report

AMBULATORY SURGERY CENTER ASSOCIATION for AMBULATORY SURGERY CENTER ASSOCIATION

Firm
Client
Income
—
Expenses
$165,615
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R.1838/S.1001 - Ambulatory Surgical Center Quality and Access Act of 2017 H.R.1017/S.479 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R.4679 - Ensuring Equal Access to Treatments Act of 2017 H.R.5804 - Post-Surgical Injections as an Opioid Alternative Act H.R.5809 - Postoperative Opioid Prevention Act of 2018 H.R.6138 - ASC Payment Transparency Act of 2018 H.R.5674 - VA MISSION Act of 2018 H.R.4783/S.2239 - Veterans Deserve Better Act Reform of Medicare payments to ASCs Reform of Medicare regulations dealing with ASCs

LobbyistCovered position, as disclosed
JEFF EVANS New —
HEATHER FALEN ASHBY —

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4783 (115th), S. 1001 (115th), S. 2239 (115th), H.R. 1017 (115th), H.R. 6138 (115th), S. 479 (115th), H.R. 5674 (115th), H.R. 5809 (115th), H.R. 1838 (115th), H.R. 4679 (115th), H.R. 5804 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.